| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | US20010051722 Aminoaryl Oxazolidinone N-oxides |
| 12/13/2001 | US20010051708 Purifying antibody; prepare antibody suspension, mix with water soluble liquid, recover clarified antibody, apply to chromatography column, elute antibody, concentrate antibody |
| 12/13/2001 | US20010051656 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction |
| 12/13/2001 | US20010051650 Topical compositions comprising ascomycins |
| 12/13/2001 | US20010051646 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 12/13/2001 | US20010051609 Administering Dna |
| 12/13/2001 | US20010051170 Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter |
| 12/13/2001 | US20010051169 Halogenated alkylnyl carbamate and a saturated or unsaturated acylic, cyclic polyol or polyol ether for the treatment of inflammatory and/or desquamating skin disorders associated with Malassezia species; antidandruff agent |
| 12/13/2001 | US20010051153 Grampositive bacteria; gastrointestinal disorders |
| 12/13/2001 | DE10127922A1 New organophosphorous-substituted hydroxamic acid compounds, useful as pre- or post-emergence selective herbicides in crops such as rice |
| 12/13/2001 | DE10101324C1 New 1-(dimercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, are stable matrix metalloproteinase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn |
| 12/13/2001 | CA2412386A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2412326A1 Stabilized hmg-coa reductase inhibitor pharmaceutical compositions |
| 12/13/2001 | CA2412197A1 Powder compositions |
| 12/13/2001 | CA2411859A1 Novel oxazolidinone derivatives and a process for the preparation thereof |
| 12/13/2001 | CA2411596A1 Therapeutic agents - ii |
| 12/13/2001 | CA2411578A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 12/13/2001 | CA2411536A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| 12/13/2001 | CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | CA2411354A1 Methods of treating viral diseases with il-18 and il-18 combinations |
| 12/13/2001 | CA2411342A1 Non-antibacterial tetracycline as anti-fungal agents |
| 12/13/2001 | CA2410577A1 Method for treating respiratory disorders associated with pulmonary elastic fiber injury |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409123A1 Heterocycle derivatives and methods of use |
| 12/13/2001 | CA2409015A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/13/2001 | CA2381249A1 Methods and compositions for modulating oxidized ldl transport |
| 12/12/2001 | EP1162458A1 Methods and compositions for modulating oxidized LDL transport |
| 12/12/2001 | EP1162263A1 Nucleozymes |
| 12/12/2001 | EP1162206A2 Peptide nucleic acids |
| 12/12/2001 | EP1162196A1 Fused-ring compounds and use thereof as drugs |
| 12/12/2001 | EP1161956A1 Medicinal compositions |
| 12/12/2001 | EP1161953A2 IBDV strain for in OVO administration |
| 12/12/2001 | EP1161952A2 Human therapeutic uses of BPI protein products |
| 12/12/2001 | EP1161947A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
| 12/12/2001 | EP1161946A2 Soluble analogs of probucol |
| 12/12/2001 | EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 12/12/2001 | EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161440A1 Method for refolding molecules of polypeptides containing ig domains |
| 12/12/2001 | EP1161439A1 Xylo-lna analogues |
| 12/12/2001 | EP1161438A1 6-o-substituted macrolides having antibacterial activity |
| 12/12/2001 | EP1161427A1 Improved process for asymmetric hydrogenation |
| 12/12/2001 | EP1161423A1 Thiazolyl urea derivatives and their utilization as antiviral agents |
| 12/12/2001 | EP1161419A1 Spirocyclic ketones and their use as tachykinin antagonists |
| 12/12/2001 | EP1161264A1 Polymer compositions for polynucleotide delivery |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161259A1 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 12/12/2001 | EP1161247A1 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 12/12/2001 | EP1161240A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/12/2001 | EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 12/12/2001 | EP1161231A2 Method of inhibiting a chaperone protein |
| 12/12/2001 | EP1161150A1 Therapeutic antimicrobial compositions |
| 12/12/2001 | EP1161146A1 Deep penetrating antimicrobial compositions |
| 12/12/2001 | EP0999851B1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 12/12/2001 | EP0966431B1 Salicylic acid-sphingoid base derivatives and uses thereof |
| 12/12/2001 | EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 12/12/2001 | EP0874854B1 Cephalosporin antibiotics |
| 12/12/2001 | EP0854708B1 Lipid alcohols as new immunosuppressive and antiviral drugs |
| 12/12/2001 | EP0828502B1 Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field |
| 12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
| 12/12/2001 | EP0782456B1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 12/12/2001 | EP0748319B1 Process for making an epoxide |
| 12/12/2001 | EP0728002B1 Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 7 infection |
| 12/12/2001 | EP0662946B2 Unsaturated aliphatic dicarboxylic acids |
| 12/12/2001 | EP0655921B1 Novel glucan preparation |
| 12/12/2001 | EP0651789B1 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 12/12/2001 | EP0626858B1 Use of protease inhibitors as antiviral agents |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326508A Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 12/12/2001 | CN1326460A B-membered azalides and their use as antibiotic agents |
| 12/12/2001 | CN1326456A 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives |
| 12/12/2001 | CN1326441A 4-Aroyl-Piperidin-CCR-3 receptor antagonists III |
| 12/12/2001 | CN1326440A Piperdine CCR-3 receptor antagonists |
| 12/12/2001 | CN1326364A Antiviral formulations comprising propylene glycol and isopropyl alkanoic acid ester |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/12/2001 | CN1326358A Method of DNA vaccination |
| 12/12/2001 | CN1326356A Method of treating viral hemorrhagic fever |
| 12/12/2001 | CN1326349A Antiviral combinations of lamivudine and adefovir |
| 12/12/2001 | CN1326335A Process for the manufacture of liquid filled capsules |
| 12/12/2001 | CN1325850A Acetyl pyrrolidone cephlosporins with basic substitutent group |
| 12/12/2001 | CN1325731A Living toxic-reduced bacteria as vaccine |
| 12/12/2001 | CN1325726A Guling ointment |
| 12/12/2001 | CN1325721A Medicine for treating viral diseases |
| 12/12/2001 | CN1325720A Medicinal composition for treating tuberculosis and its preparing process |
| 12/12/2001 | CN1325702A Medicine for treating typhoid |
| 12/12/2001 | CN1325698A Method for treating bacterial infection-type dermatopath and its preparing process and application |
| 12/12/2001 | CN1076021C L-2',3'-dideoxy nucleoside analogs as antihepatitis B (HBV) and anti-HIV agents |
| 12/12/2001 | CN1076019C Preparation of triazoles by organometallic addition to ketonts and intermediates therefor |
| 12/11/2001 | US6329524 Cyclic sulfone containing retroviral protease inhibitors |
| 12/11/2001 | US6329512 Isolating specific outer membrane proteins from haemophilus strain from cell paste using extraction, concentration and purification steps; for increasing immunogenicity of streptococcus capsular polysaccharide used as vaccine |
| 12/11/2001 | US6329498 Amino acid sequence; stable preparation for treatment of human immunodeficiency virus |
| 12/11/2001 | US6329417 Hepatitis C inhibitor tri-pepitides |
| 12/11/2001 | US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same |
| 12/11/2001 | US6329399 Antifungal amine derivatives and processing for producing the same |
| 12/11/2001 | US6329397 Hydroxy pipecolate hydroxamic acid derivatives |
| 12/11/2001 | US6329391 Antibiotics, bactericides using quinolones |